Scientists have studied the effect of hormone therapy on women's heart health
Hormone replacement therapy is used to alleviate the symptoms of menopause, but its effect on the cardiovascular system remains the subject of scientific debate. International recommendations take into account a woman's age, the time of initiation of treatment, and her state of health. A new long-term study conducted in Israel did not reveal an increased risk of heart attack, stroke, and blood clots in women who received modern versions of such therapy. The results of the work and its limitations are described in the Izvestia article.
Observations for 12 years
The researchers analyzed the medical data of 52,330 women aged 45 to 59 years. The participants had no previously diagnosed cardiovascular diseases, blood clots, or cancers. About half of them started receiving hormone replacement therapy, while the rest went to a gynecologist, but did not take hormones.
The average follow-up period was 12 years, and the maximum was 23 years. The researchers compared the frequency of cardiovascular events, including heart attacks and strokes, blood clots, and deaths before the age of 80. The work was carried out by the American Heart Association (AHA) and published on the News Medical portal.
Ronen Arbel, Head of the study
Concerns that hormone replacement therapy may affect the heart are one of the most common reasons why women refuse hormone treatment for menopausal symptoms, and some medical professionals may be hesitant to offer it.
Comparable indicators
During follow-up, a heart attack, stroke, or other related cardiovascular event was registered in 2,311 women from the hormone therapy group (4.4%). Among those who did not take hormones, such events occurred in 2,383 participants, or 4.6%.
The differences were small in other indicators as well. Blood clots were detected in 174 women receiving therapy and 175 participants in the control group — in both cases, this is 0.33%. 659 women from the first group (1.3%) and 653 from the second (1.2%) died before the age of 80.
Comparable results were obtained when comparing different methods of hormone administration: in the form of tablets, patches and gels. The authors reported that in the studied group of women, the initiation of modern hormone therapy was not accompanied by an increase in the frequency of these complications.
Why are there concerns
Previously published studies have yielded mixed results regarding the effect of hormone replacement therapy on the cardiovascular system. According to the authors of the new work, some of the previous data was obtained by studying treatment regimens that are now used less frequently, higher doses of hormones, and women who started therapy a considerable time after menopause.
Current recommendations from the American College of Obstetricians and Gynecologists suggest that, if indicated, hormone therapy should be considered for 10 years after menopause and until the age of 60. However, the decision on treatment depends not only on age: the doctor must take into account individual risk factors and the woman's state of health.
Stacy Rosen, AHA Women's Health Expert
For many women, menopausal symptoms can significantly affect their quality of life, but questions about the safety of hormone therapy for the cardiovascular system remain open. <...> These results may help women and their healthcare professionals to have more informed conversations about the benefits and risks of treatment based on their individual health needs.
The results need to be checked
The authors emphasize that the study was observational. This makes it possible to identify a link between receiving therapy and the state of health, but it does not prove that hormonal treatment was the reason for the absence of an increase in cardiovascular risk. The researchers compared the participants by age, body mass index, blood pressure, cholesterol levels, diabetes, smoking, and socio-economic status.
At the same time, medical records might not contain detailed information about nutrition, physical activity, other diseases, and the severity of menopausal symptoms. In addition, the researchers took into account the initial version of hormone therapy, but did not track all changes in drugs and treatment regimens over the following years.
According to the publication, the conclusions are considered preliminary and require further verification. They belong to the studied group of women aged 45-59 years without a history of certain diseases and do not mean that hormone therapy is equally safe for everyone.
Переведено сервисом «Яндекс Переводчик»